FDA relocated the offices and laboratories of the Center for Biologics Evaluation and Research (CBER) from locations in Bethesda and Rockville, Maryland to the FDA White Oak campus in Silver Spring, Maryland in 2014.
Transfusion/Donation Fatalities, provides the current contact information and describes the notification process for transfusion related fatalities and donation related deaths required under
21 CFR 606.170(b).
The webpage also provides related information, including the
Guidance for Industry: Notifying FDA of Fatalities Related to Blood Collection or Transfusion and annual fatality reports.